Precision oncology has delivered an unprecedented expansion of molecularly targeted therapies, yet patient selection remains the defining unmet need of the field. Too many patients
Ovarian cancer remains a major global health burden among women, ranking eighth in both cancer incidence and cancer mortality worldwide in 2024, with an estimated 330,731 new cases
This is a narrative review article synthesizing mechanistic knowledge and emerging concepts about lung tumour secretome and extracellular vesicles, raising questions about biomarker and therapeutic potential rather than reporting original empirical results.